Patents by Inventor Stéphane Eeckhoudt

Stéphane Eeckhoudt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for cell transplantation
    Patent number: 10478459
    Abstract: The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition with procoagulant cells and at least one factor Xa inhibitor, preferably rivaroxaban, as well as at least one thrombin inhibitor, preferably bivalirudin.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: November 19, 2019
    Assignee: UNIVERSITE CATHOLIQUE DE LOUVAIN
    Inventors: Xavier Stephenne, Etienne Sokal, Mustapha Najimi, Stéphane Eeckhoudt, Cédric Hermans
  • Compositions and methods for cell transplantation
    Patent number: 10039789
    Abstract: The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition comprising procoagulant cells and at least one antithrombin activator, preferably unfractionated heparin, as well as at least one thrombin inhibitor, preferably bivalirudin.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: August 7, 2018
    Assignee: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Xavier Stephenne, Etienne Sokal, Mustapha Najimi, Stéphane Eeckhoudt, Cédric Hermans
  • COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
    Publication number: 20170354723
    Abstract: The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition with procoagulant cells and at least one factor Xa inhibitor, preferably rivaroxaban, as well as at least one thrombin inhibitor, preferably bivalirudin.
    Type: Application
    Filed: August 25, 2017
    Publication date: December 14, 2017
    Inventors: Xavier Stephenne, Etienne Sokal, Mustapha Najimi, Stéphane Eeckhoudt, Cédric Hermans
  • Factor Xa inhibitor used with liver-derived progenitor cells
    Patent number: 9775890
    Abstract: The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition comprising procoagulant cells and at least one factor Xa inhibitor, preferably rivaroxaban, as well as at least one thrombin inhibitor, preferably bivalirudin.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: October 3, 2017
    Assignee: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Xavier Stephenne, Etienne Sokal, Mustapha Najimi, Stéphane Eeckhoudt, Cédric Hermans
  • COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
    Publication number: 20170042940
    Abstract: The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition comprising procoagulant cells and at least one antithrombin activator, preferably unfractionated heparin, as well as at least one thrombin inhibitor, preferably bivalirudin.
    Type: Application
    Filed: October 6, 2016
    Publication date: February 16, 2017
    Inventors: Xavier Stephenne, Etienne Sokal, Mustapha Najimi, Stéphane Eeckhoudt, Cédric Hermans
  • COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
    Publication number: 20150037291
    Abstract: The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition comprising procoagulant cells and at least one factor Xa inhibitor, preferably rivaroxaban, as well as at least one thrombin inhibitor, preferably bivalirudin.
    Type: Application
    Filed: June 15, 2012
    Publication date: February 5, 2015
    Applicant: UNIVERSITE CATHOLIQUE DE LOUVAIN
    Inventors: Xavier Stephenne, Etienne Sokal, Mustapha Najimi, Stéphane Eeckhoudt, Cédric Hermans
  • COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
    Publication number: 20130302291
    Abstract: The present invention relates to compositions and methods for cell transplantation. In particular, the present invention provides a composition comprising procoagulant cells and at least one antithrombin activator, preferably unfractionated heparin, as well as at least one thrombin inhibitor, preferably bivalirudin.
    Type: Application
    Filed: January 25, 2012
    Publication date: November 14, 2013
    Applicant: UNIVERSITE CATHOLIQUE DE LOUVAIN
    Inventors: Xavier Stephenne, Etienne Sokal, Mustapha Najimi, Stephane Eeckhoudt, Cedric Hermans